1076 related articles for article (PubMed ID: 17502554)
1. Imaging beta-amyloid burden in aging and dementia.
Rowe CC; Ng S; Ackermann U; Gong SJ; Pike K; Savage G; Cowie TF; Dickinson KL; Maruff P; Darby D; Smith C; Woodward M; Merory J; Tochon-Danguy H; O'Keefe G; Klunk WE; Mathis CA; Price JC; Masters CL; Villemagne VL
Neurology; 2007 May; 68(20):1718-25. PubMed ID: 17502554
[TBL] [Abstract][Full Text] [Related]
2. PET imaging of brain amyloid in dementia: a review.
Quigley H; Colloby SJ; O'Brien JT
Int J Geriatr Psychiatry; 2011 Oct; 26(10):991-9. PubMed ID: 21905095
[TBL] [Abstract][Full Text] [Related]
3. Imaging amyloid deposition in Lewy body diseases.
Gomperts SN; Rentz DM; Moran E; Becker JA; Locascio JJ; Klunk WE; Mathis CA; Elmaleh DR; Shoup T; Fischman AJ; Hyman BT; Growdon JH; Johnson KA
Neurology; 2008 Sep; 71(12):903-10. PubMed ID: 18794492
[TBL] [Abstract][Full Text] [Related]
4. β-Amyloid in Lewy body disease is related to Alzheimer's disease-like atrophy.
Shimada H; Shinotoh H; Hirano S; Miyoshi M; Sato K; Tanaka N; Ota T; Fukushi K; Irie T; Ito H; Higuchi M; Kuwabara S; Suhara T
Mov Disord; 2013 Feb; 28(2):169-75. PubMed ID: 23225334
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal patterns of β-amyloid deposition in nondemented older adults.
Sojkova J; Zhou Y; An Y; Kraut MA; Ferrucci L; Wong DF; Resnick SM
Arch Neurol; 2011 May; 68(5):644-9. PubMed ID: 21555640
[TBL] [Abstract][Full Text] [Related]
6. Amyloid PET imaging in patients with mild cognitive impairment: a 2-year follow-up study.
Koivunen J; Scheinin N; Virta JR; Aalto S; Vahlberg T; Någren K; Helin S; Parkkola R; Viitanen M; Rinne JO
Neurology; 2011 Mar; 76(12):1085-90. PubMed ID: 21325653
[TBL] [Abstract][Full Text] [Related]
7. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
[TBL] [Abstract][Full Text] [Related]
8. PET Radioligands Reveal the Basis of Dementia in Parkinson's Disease and Dementia with Lewy Bodies.
Gomperts SN; Marquie M; Locascio JJ; Bayer S; Johnson KA; Growdon JH
Neurodegener Dis; 2016; 16(1-2):118-24. PubMed ID: 26655867
[TBL] [Abstract][Full Text] [Related]
9. Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases.
Gomperts SN; Locascio JJ; Makaretz SJ; Schultz A; Caso C; Vasdev N; Sperling R; Growdon JH; Dickerson BC; Johnson K
JAMA Neurol; 2016 Nov; 73(11):1334-1341. PubMed ID: 27654968
[TBL] [Abstract][Full Text] [Related]
10. Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia.
Bourgeat P; Chételat G; Villemagne VL; Fripp J; Raniga P; Pike K; Acosta O; Szoeke C; Ourselin S; Ames D; Ellis KA; Martins RN; Masters CL; Rowe CC; Salvado O;
Neurology; 2010 Jan; 74(2):121-7. PubMed ID: 20065247
[TBL] [Abstract][Full Text] [Related]
11. Amyloid imaging of Lewy body-associated disorders.
Foster ER; Campbell MC; Burack MA; Hartlein J; Flores HP; Cairns NJ; Hershey T; Perlmutter JS
Mov Disord; 2010 Nov; 25(15):2516-23. PubMed ID: 20922808
[TBL] [Abstract][Full Text] [Related]
12. High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorders is associated with dementia.
Vijayaraghavan S; Maetzler W; Reimold M; Lithner CU; Liepelt-Scarfone I; Berg D; Darreh-Shori T
Alzheimers Dement; 2014 Sep; 10(5):530-540.e1. PubMed ID: 23978325
[TBL] [Abstract][Full Text] [Related]
13. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.
Villemagne VL; Burnham S; Bourgeat P; Brown B; Ellis KA; Salvado O; Szoeke C; Macaulay SL; Martins R; Maruff P; Ames D; Rowe CC; Masters CL;
Lancet Neurol; 2013 Apr; 12(4):357-67. PubMed ID: 23477989
[TBL] [Abstract][Full Text] [Related]
14. Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition.
Storandt M; Mintun MA; Head D; Morris JC
Arch Neurol; 2009 Dec; 66(12):1476-81. PubMed ID: 20008651
[TBL] [Abstract][Full Text] [Related]
15. Aβ-amyloid deposition in patients with Parkinson disease at risk for development of dementia.
Petrou M; Bohnen NI; Müller ML; Koeppe RA; Albin RL; Frey KA
Neurology; 2012 Sep; 79(11):1161-7. PubMed ID: 22933741
[TBL] [Abstract][Full Text] [Related]
16. [11C]PIB binding in Parkinson's disease dementia.
Maetzler W; Reimold M; Liepelt I; Solbach C; Leyhe T; Schweitzer K; Eschweiler GW; Mittelbronn M; Gaenslen A; Uebele M; Reischl G; Gasser T; Machulla HJ; Bares R; Berg D
Neuroimage; 2008 Feb; 39(3):1027-33. PubMed ID: 18035558
[TBL] [Abstract][Full Text] [Related]
17. Clinical features of Pittsburgh compound-B-negative dementia.
Takeuchi J; Shimada H; Ataka S; Kawabe J; Mori H; Mizuno K; Wada Y; Shiomi S; Watanabe Y; Miki T
Dement Geriatr Cogn Disord; 2012; 34(2):112-20. PubMed ID: 22947919
[TBL] [Abstract][Full Text] [Related]
18. Brain amyloid and cognition in Lewy body diseases.
Gomperts SN; Locascio JJ; Marquie M; Santarlasci AL; Rentz DM; Maye J; Johnson KA; Growdon JH
Mov Disord; 2012 Jul; 27(8):965-73. PubMed ID: 22693110
[TBL] [Abstract][Full Text] [Related]
19. In vitro characterization of Pittsburgh compound-B binding to Lewy bodies.
Fodero-Tavoletti MT; Smith DP; McLean CA; Adlard PA; Barnham KJ; Foster LE; Leone L; Perez K; Cortés M; Culvenor JG; Li QX; Laughton KM; Rowe CC; Masters CL; Cappai R; Villemagne VL
J Neurosci; 2007 Sep; 27(39):10365-71. PubMed ID: 17898208
[TBL] [Abstract][Full Text] [Related]
20. Long night's journey into the day: amyloid-β imaging in Alzheimer's disease.
Villemagne VL; Rowe CC
J Alzheimers Dis; 2013; 33 Suppl 1():S349-59. PubMed ID: 22710919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]